Novel Human N-Acetyltransferase 2 Alleles That Differ in Mechanism for Slow Acetylator Phenotype

This publication has 15 references indexed in Scilit:

• MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
  Annual Review of Pharmacology and Toxicology, 1997
• Determination of HumanNAT2Acetylator Genotype by Restriction Fragment-Length Polymorphism and Allele-Specific Amplification
  Analytical Biochemistry, 1995
• Enzyme kinetic properties of human recombinant arylamine n-acetyltransferase 2 allotypic variants expressed in Escherichia coli
  Biochemical Pharmacology, 1995
• Nomenclature for N-acetyltransferases
  Pharmacogenetics, 1995
• Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes
  Human Molecular Genetics, 1994
• The Structure and Characteristics of a Fourth Allele of Polymorphic N-Acetyltransferase Gene Found in the Japanese Population
  Biochemical and Biophysical Research Communications, 1993
• Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
  Journal of Clinical Investigation, 1990
• Genomic sequencing.
  Proceedings of the National Academy of Sciences, 1984
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
  Analytical Biochemistry, 1983
• ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER
  The Lancet, 1982